Business Wire

FDA Approves ORTHOVISC for Treating Osteoarthritis of the Knee; Anika to Receive $20 Million Milestone Payment from U.S. Marketing Partner

ORTHOVISC is injected into the knee joint in a series of intra-articular injections one week apart. Clinical Synopsis The FDA approval of ORTHOVISC is based on integrated effectiveness data from two ...
The Business Journals

Anika gets FDA OK for Orthovisc, triggering $20M milestone

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The U.S. Food and Drug Administration (FDA) has given ...
Healio

Meta-analysis: Hyaluronan injections superior to corticosteroids in OA treatment

Please provide your email address to receive an email when new articles are posted on . Given the potentially deadly side effects of NSAIDs and COX-2 inhibitors, hyaluronan injections look more and ...
Seeking Alpha

Bullish On Anika Therapeutics's Pullback As Integrity Scales

Anika Therapeutics is refocusing on HA-based OA pain management and regenerative orthopedic products. The main drivers here are Monovisc, Orthovisc, and Integrity. Particularly, ANIK’s Integrity ...